# A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks

> **NCT00457106** · NA · COMPLETED · sponsor: **Beth Israel Medical Center** · enrollment: 90 (estimated)

## Conditions studied

- Major Depression With Panic Attacks
- Panic Disorder

## Interventions

- **DRUG:** Paroxetine
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00457106
- **Lead sponsor:** Beth Israel Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457106, "A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00457106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*